bibliographicCitation |
Siegfried JM, Gubish CT, Rothstein ME, Henry C, Stabile LP. Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2012 Mar;7(3):485–95. doi: 10.1097/jto.0b013e31824177ea. |